Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Overview Rating
Good
Haemonetics (NYSE:HAE) Stock Quotes, Forecast and News Summary
Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Haemonetics (HAE) stock?
You can purchase shares of Haemonetics (NYSE:HAE) through any online brokerage.
Who are Haemonetics (HAE) competitors?
Other companies in Haemonetics’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
What is the forecast, or price target, for Haemonetics (HAE) stock?
Haemonetics has a consensus price target of $103.09.
What is the current price for Haemonetics (HAE)?
The stock price for Haemonetics (NYSE: HAE) is $86.4 last updated November 22, 2024 at 5:03 AM EST.
Does Haemonetics (HAE) pay a dividend?
There are no upcoming dividends for Haemonetics.
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics’s Q3 earnings are confirmed for Thursday, February 6, 2025.
Is Haemonetics (HAE) going to split?
There is no upcoming split for Haemonetics.
What sector and industry does Haemonetics (HAE) operate in?
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.